Novo Nordisk A/S ADR buy melinda
Start price
01.09.17
/
50%
€43.06
Target price
29.12.17
€49.61
Performance (%)
13.28%
End price
29.12.17
€48.78
Summary
This prediction ended on 29.12.17 with a price of €48.78. The BUY prediction by melinda finished with a performance of 13.28%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 1.172% | 1.172% | -30.749% | -60.154% |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% | 60.124% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% | 101.416% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% | 47.915% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% | 64.215% |
According to melinda what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Insulin-Pen
Diabetes
Trends Technische Analyse Novo Nordisk A / S
kurzfristig mittelfristig langfristig Trends Trosse Trosse Trosse
(Vom Mitglied beendet)
Stopped prediction by melinda for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€44.70
28.12.25
28.12.25
-
28.12.26
28.12.26
0.22%
03.01.26
03.01.26
Could be worthwhile Investment >10% per year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€158.50
14.05.23
14.05.23
€165.00
14.05.24
14.05.24
-22.71%
15.05.24
15.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.74
01.09.17
01.09.17
€55.00
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.07
06.07.17
06.07.17
€50.00
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.95
06.07.17
06.07.17
€45.10
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€32.79
17.01.17
17.01.17
€33.37
24.04.17
24.04.17
2.29%
24.04.17
24.04.17